Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

BearDownAZ

Apr 27, 2020 12:42PM

barsax

Rank: Vice President [?]

Points: 848 [?]

Votes: 11 Score: 3.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

in response to

Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

BearDownAZ

posted on Apr 27, 2020 01:10PM

Julien Potet

@julienpotet

Good news. 129 moderate or severe patients w/ #COVID19. 65 in #tocilizumab arm, 64 in control arm. Endpoint: death or need for mechanical ventilation by D14. Tocilizumab signficantly superior to control arm. Publication will follow soon 1/2

3 Recommendations

Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

KOO-KOO2

Apr 27, 2020 01:10PM

Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

BearDownAZ

Apr 27, 2020 02:27PM

Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

barsax

Apr 27, 2020 02:39PM

Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies